Research Progress in Modified Gegen Qinlian Decoction for the Treatment of Ulcerative Colitis
Journal of Clinical Medicine Research · 15.07.2026 · 7 (2) · 321
DOI: 10.32629/jcmr.v7i2.5331 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine Research, online erschienen am 15.07.2026. Verfasst von Na Yang und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Ulcerative colitis is a common chronic inflammatory bowel disease with insidious onset and recurrent episodes. Although Western medicine can maintain clinical remission, it still fails to meet patients' therapeutic expectations. Gegen Qinlian Decoction improves intestinal mucosal barrier function and attenuates systemic and tissue inflammatory responses with remarkable clinical efficacy. This article reviews the research progress of modified Gegen Qinlian Decoction in the treatment of ulcerative colitis, aiming to provide a theoretical basis for the clinical diagnosis and treatment of ulcerative colitis.
Zitieren
APA
Yang, N., & Liu, Y. (2026). Research Progress in Modified Gegen Qinlian Decoction for the Treatment of Ulcerative Colitis. Journal of Clinical Medicine Research, 7(2), 321. https://doi.org/10.32629/jcmr.v7i2.5331
Vancouver
Yang N, Liu Y. Research Progress in Modified Gegen Qinlian Decoction for the Treatment of Ulcerative Colitis. Journal of Clinical Medicine Research. 2026;7(2):321. doi:10.32629/jcmr.v7i2.5331
BibTeX
@article{Yang2026,
author = {Yang, Na and Liu, Yueyang},
title = {Research Progress in Modified Gegen Qinlian Decoction for the Treatment of Ulcerative Colitis},
journal = {Journal of Clinical Medicine Research},
year = {2026},
volume = {7},
number = {2},
pages = {321},
doi = {10.32629/jcmr.v7i2.5331}
}
EUVIMED